Get the Stockscreener App
88.68
0.44%
0.36
After Hours:
88.68
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $88.68, with a volume of 1.18M.
It is up +0.44% in the last 24 hours and down -12.44% over the past month.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$88.32
Open:
$88.3
24h Volume:
1.18M
Relative Volume:
0.95
Market Cap:
$10.45B
Revenue:
$2.77B
Net Income/Loss:
$286.61M
P/E Ratio:
37.74
EPS:
2.35
Net Cash Flow:
$524.11M
1W Performance:
-6.10%
1M Performance:
-12.44%
6M Performance:
-27.51%
1Y Performance:
-26.19%
1-Day Range:
$87.81
$89.78
1-Week Range:
$85.80
$95.63
52-Week Range:
$85.80
$129.50
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
88.68 | 10.40B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
466.42 | 174.85B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.04 | 141.13B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.94 | 43.07B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.89 | 32.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
183.93 | 31.02B | 15.50B | 1.33B | 2.16B | 7.34 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Earnings Preview: What to Expect From Revvity's Report - MSN
What's Going On With Revvity Stock Today? - 富途牛牛
Revvity Inc.’s Price Action Aligns with Quant SignalsBreakout Confirmation With Entry Tracker Enabled - metal.it
Shareholders Will Be Pleased With The Quality of Revvity's (NYSE:RVTY) Earnings - 富途牛牛
Is it the right time to buy Revvity Inc. stockTurn volatility into profit opportunities - Jammu Links News
What are Revvity Inc. company’s key revenue driversOutstanding capital appreciation - Jammu Links News
What are the technical indicators suggesting about Revvity Inc.Consistent high-performance stocks - Jammu Links News
How does Revvity Inc. generate profit in a changing economyConsistently superior profits - Jammu Links News
What is the dividend policy of Revvity Inc. stockCapitalize on market momentum for maximum profit - Jammu Links News
Revvity, Inc. Stock (RVTY) Opinions on Quarterly Earnings Report - Quiver Quantitative
What is the risk reward ratio of investing in Revvity Inc. stockUnlock steady growth with low-risk stocks - Jammu Links News
Is Revvity Inc. a good long term investmentExceptional trading results - Jammu Links News
Does Revvity Inc. stock perform well during market downturnsInvest confidently with real-time updates - Jammu Links News
How many analysts rate Revvity Inc. as a “Buy”Achieve consistent double-digit growth - Jammu Links News
Why is Revvity Inc. stock attracting strong analyst attentionFree Capital Efficiency Planning - Jammu Links News
When is Revvity Inc. stock expected to show significant growthGain the edge with real-time market data - Jammu Links News
What institutional investors are buying Revvity Inc. stockHigh-yield trading alerts - Jammu Links News
How strong is Revvity Inc. company’s balance sheetFree Technical Analysis Support - Jammu Links News
Stock Analysis | Revvity OutlookA Cautious Approach Amid Mixed Signals - AInvest
Is Revvity Inc. a growth stock or a value stockBest Dividend Forecasts To Watch Now - Jammu Links News
Revvity stock hits 52-week low at 87.63 USD - Investing.com Australia
Tesla, AMD, SMCI, Nike, Revvity: Stocks Making The Biggest Moves Today - Stocktwits
Revvity price target lowered to $110 from $120 at Stifel - Yahoo Finance
A Quick Look at Today's Ratings for Revvity(RVTY.US), With a Forecast Between $102 to $115 - 富途牛牛
Revvity, Inc. Earnings Call: Mixed Sentiment and Strategic Moves - The Globe and Mail
Revvity Repeat Insider Selling Not A Positive Indicator - 富途牛牛
Revvity Inc. Earnings Report Breakdown: What Investors Should KnowMulti-Bagger Potential Stock Forecast Tools Released - metal.it
Revvity targets 2%-4% organic growth for 2025 as China diagnostics faces new policy headwinds - MSN
Stifel lowers Revvity stock price target to $110 on China ImmunoDx pressures - Investing.com Nigeria
Stifel lowers Revvity stock price target to $110 on China ImmunoDx pressures By Investing.com - Investing.com South Africa
Raymond James lowers Revvity stock price target to $115 on China headwinds - Investing.com Nigeria
Revvity price target lowered to $115 from $120 at Raymond James - TipRanks
Revvity, Inc. (NYSE:RVTY) Q2 2025 Earnings Call Transcript - Insider Monkey
Revvity stock price target lowered to $115 by Bernstein on China headwinds - Investing.com
Revvity's Struggles in a Post-Pandemic Market: Is a Dividend Cut Looming? - AInvest
Revvity: Not A Healthy Diagnosis For This Life Science Business (NYSE:RVTY) - Seeking Alpha
Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ... - Yahoo Finance
Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ... By GuruFocus - Investing.com Canada
Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’ - Stocktwits
Revvity’s Resilience: Strong Performance and Growth Opportunities Amidst Challenges - TipRanks
Revvity trims 2025 profit forecast as China policy changes hit diagnostics demand - MSN
Revvity Stock Sinks on Lowered China Immunodiagnostics Outlook - MSN
U.S. Markets Closed Mixed Monday As Super Micro Computer Led, Revvity Lagged - Barron's
Revvity trims 2025 profit forecast on soft demand for diagnostics in China - 1470 & 100.3 WMBD
Why Revvity (RVTY) Stock Is Falling Today - MSN
Revvity Q2: Headwinds From China And Customers, Buy On Weakness (NYSE:RVTY) - Seeking Alpha
Revvity stock price target lowered to $100 at Jefferies on China headwinds - Investing.com Nigeria
Revvity stock price target lowered to $100 at Jefferies on China headwinds By Investing.com - Investing.com South Africa
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.50%
2.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):